Basic info
Industry
biotechnology research
Sectors
Biotechnology
biotechnology
Health Care
drug development
Medical
short bowel syndrome
Rare Disease
Date founded
2019
Funding rounds raised
Total raised
$125M
from 21 investors over 21 rounds
V
VectivBio AG raised $125M on October 13, 2022
Investors: TCG X, Surveyor Capital, OrbiMed Advisors, Eventide Asset Management, Marshall Wace, Vivo Capital, Driehaus Capital Management LLC and Forbion
V
VectivBio AG raised $54M on June 29, 2022
Investors: Forbion
V
VectivBio AG raised $75M on March 30, 2022
Investors: Kreos Capital
V
VectivBio AG raised $110M on October 19, 2020
Investors: Versant Ventures, Cormorant Capital, Surveyor Capital, Eventide Asset Management, Novo Holdings, OrbiMed Advisors and Tekla Capital Management
V
VectivBio AG raised $35M on January 8, 2020
Investors: Versant Ventures, Novo Holdings, Tekla Capital Management and OrbiMed Advisors